共 50 条
- [41] Risk Factors of Radiation Pneumonitis After Stereotactic Ablative Body Radiation Therapy for Primary and Metastatic Lung Tumors [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E461 - E462
- [42] Clinical Results of Stereotactic Body Radiation Therapy for Primary or Metastatic Liver Tumors [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S280 - S281
- [44] Is the Fear of Postprostatectomy Radiation Therapy Justified?: An Analysis of Patient-Reported Quality of Life Following Adjuvant or Salvage Radiation [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S460 - S461
- [46] Dosimetric Correlations With Patient-Reported Urinary and Bowel Symptoms After Stereotactic Body Radiation Therapy for Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E273 - E273
- [47] Utilization of Patient-Reported Outcomes to Guide Symptom Management During Stereotactic Body Radiation Therapy for Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E536 - E536
- [48] Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer: Predicting Patient-Reported Sexual Function at 2 Years [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E224 - E224
- [49] Quality of patient-reported outcome measures for primary dysmenorrhea: a systematic review [J]. Quality of Life Research, 2024, 33 : 31 - 43
- [50] Stereotactic Body Radiation Therapy for Prostate Cancer: What Is the Appropriate Patient-Reported Outcome for Clinical Trial Design? [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S705 - S705